MST CONTINUS

This brand name is authorized in Croatia, Cyprus, Estonia, Ireland, Malta, Poland, South Africa, UK.

Active ingredients

The drug MST CONTINUS contains one active pharmaceutical ingredient (API):

1	Morphine UNII X3P646A2J0 - MORPHINE SULFATE
	Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation.
	Read more about Morphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MST CONTINUS Prolonged release granules for oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
MST CONTINUS Prolonged-release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AA01	Morphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1033276, 1080278, 1080289, 1080290
GB	Medicines & Healthcare Products Regulatory Agency	19201, 19204, 19209, 28834, 28838, 30779, 30788, 381005, 381007, 381524, 381526, 381528, 381531, 381534, 391224, 391226, 40884, 40893, 43796
HR	Agencija za lijekove i medicinske proizvode	HR-H-113395944, HR-H-448781299, HR-H-734333555, HR-H-863692829
IE	Health Products Regulatory Authority	35130, 35149, 35157, 35165, 53341, 53368
MT	Medicines Authority	AA729/33201
PL	Rejestru Produktów Leczniczych	100093056, 100093062, 100093079, 100093085, 100093091
ZA	Health Products Regulatory Authority	R/2.9/294, R/2.9/295, S/2.9/278, S/2.9/279